|
1
|
Schnelldorfer T, Ware AL, Sarr MG, Smyrk
TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM and
Farnell MB: Long-term survival after pancreatoduodenectomy for
pancreatic adenocarcinoma: is cure possible? Ann Surg. 247:456–462.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
House MG, Gönen M, Jarnagin WR, et al:
Prognostic significance of pathologic nodal status in patients with
resected pancreatic cancer. J Gastrointest Surg. 11:1549–1555.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arya M, Patel HR and Williamson M:
Chemokines: key players in cancer. Curr Med Res Opin. 19:557–564.
2003. View Article : Google Scholar
|
|
4
|
Dieu MC, Vanbervliet B, Vicari A, Bridon
JM, Oldham E, Aït-Yahia S, Brière F, Zlotnik A, Lebecque S and Caux
C: Selective recruitment of immature and mature dendritic cells by
distinct chemokines expressed in different anatomic sites. J Exp
Med. 188:373–386. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hirao M, Onai N, Hiroishi K, Watkins SC,
Matsushima K, Robbins PD, Lotze MT and Tahara H: CC chemokine
receptor-7 on dendritic cells is induced after interaction with
apoptotic tumor cells: critical role in migration from the tumor
site to draining lymph nodes. Cancer Res. 60:2209–2217.
2000.PubMed/NCBI
|
|
6
|
Murdoch C: CXCR4: chemokine receptor
extraordinaire. Immunol Rev. 177:175–184. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Phillips RJ, Burdick MD, Lutz M, Belperio
JA, Keane MP and Strieter RM: The stromal derived
factor-1/CXCL12-CXC chemokine receptor 4 biological axis in
non-small cell lung cancer metastases. Am J Respir Crit Care Med.
167:1676–1686. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Joukov V, Pajusola K, Kaipainen A, Chilov
D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N and Alitalo K: A
novel vascular endothelial growth factor, VEGF-C, is a ligand for
the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
EMBO J. 15:290–298. 1996.
|
|
9
|
Orlandini M, Marconcini L, Ferruzzi R and
Oliviero S: Identification of a c-fos-induced gene that is related
to the platelet-derived growth factor/vascular endothelial growth
factor family. Proc Natl Acad Sci USA. 93:11675–11680. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaipainen A, Korhonen J, Mustonen T, van
Hinsbergh VW, Fang GH, Dumont D, Breitman M and Alitalo K:
Expression of the fms-like tyrosine kinase FLT4 gene becomes
restricted to lymphatic endothelium during development. Proc Natl
Acad Sci USA. 92:3566–3570. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cabioglu N, Yazici MS, Arun B, Broglio KR,
Hortobagyi GN, Price JE and Sahin A: CCR7 and CXCR4 as novel
biomarkers predicting axillary lymph node metastasis in T1 breast
cancer. Clin Cancer Res. 11:5686–5693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Günther K, Leier J, Henning G, et al:
Predictor of lymph node metastasis in colorectal carcinoma by
expression of chemokine receptor CCR7. Int J Cancer. 116:726–733.
2005.PubMed/NCBI
|
|
13
|
Ding Y, Shimada Y, Maeda M, Kawabe A,
Kaganoi J, Komoto I, Hashimoto Y, Miyake M, Hashida H and Imamura
M: Association of CC chemokine receptor 7 with lymph node
metastasis of esophageal squamous cell carcinoma. Clin Cancer Res.
9:3406–3412. 2003.PubMed/NCBI
|
|
14
|
Heresi GA, Wang J, Taichman R, Chirinos
JA, Regalado JJ, Lichtstein DM and Rosenblatt JD: Expression of the
chemokine receptor CCR7 in prostate cancer presenting with
generalized lymphadenopathy: report of a case, review of the
literature, and analysis of chemokine receptor expression. Urol
Oncol. 23:261–267. 2005. View Article : Google Scholar
|
|
15
|
Tsuzuki H, Takahashi N, Kojima A, Narita
N, Sunaga H, Takabayashi T and Fujieda S: Oral and oropharyngeal
squamous cell carcinomas expressing CCR7 have poor prognoses. Auris
Nasus Larynx. 33:37–42. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kato M, Kitayama J, Kazama S and Nagawa H:
Expression pattern of CXC chemokine receptor-4 is correlated with
lymph node metastasis in human invasive ductal carcinoma. Breast
Cancer Res. 5:R144–R150. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Uchida D, Begum NM, Almofti A, Nakashiro
K, Kawamata H, Tateishi Y, Hamakawa H, Yoshida H and Sato M:
Possible role of stromal-cell-derived factor-1/CXCR4 signaling on
lymph node metastasis of oral squamous cell carcinoma. Exp Cell
Res. 290:289–302. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sedivy R, Beck-Mannagetta J, Haverkampf C,
Battistutti W and Hönigschnabl S: Expression of vascular
endothelial growth factor-C correlates with the lymphatic
microvessel density and the nodal status in oral squamous cell
cancer. J Oral Pathol Med. 32:455–460. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Neuchrist C, Erovic BM, Handisurya A,
Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A and
Burian M: Vascular endothelial growth factor C and vascular
endothelial growth factor receptor 3 expression in squamous cell
carcinomas of the head and neck. Head Neck. 25:464–474. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arinaga M, Noguchi T, Takeno S, Chujo M,
Miura T and Uchida Y: Clinical significance of vascular endothelial
growth factor C and vascular endothelial growth factor receptor 3
in patients with nonsmall cell lung carcinoma. Cancer. 97:457–464.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Van Trappen PO, Steele D, Lowe DG, Baithun
S, Beasley N, Thiele W, Weich H, Krishnan J, Shepherd JH, Pepper
MS, Jackson DG, Sleeman JP and Jacobs IJ: Expression of vascular
endothelial growth factor (VEGF)-C and VEGF-D, and their receptor
VEGFR-3, during different stages of cervical carcinogenesis. J
Pathol. 201:544–554. 2003.PubMed/NCBI
|
|
22
|
Hanrahan V, Currie MJ, Gunningham SP,
Morrin HR, Scott PA, Robinson BA and Fox SB: The angiogenic switch
for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C,
and VEGF-D in the adenoma-carcinoma sequence during colorectal
cancer progression. J Pathol. 200:183–194. 2003. View Article : Google Scholar
|
|
23
|
Arigami T, Natsugoe S, Uenosono Y,
Yanagita S, Arima H, Hirata M, Ishigami S and Aikou T: CCR7 and
CXCR4 expression predicts lymph node status including
micrometastasis in gastric cancer. Int J Oncol. 35:19–24. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiang Z, Zeng Z, Tang Z, Fan J, Sun H, Wu
W and Tan Y: Increased expression of vascular endothelial growth
factor-C and nuclear CXCR4 in hepatocellular carcinoma is
correlated with lymph node metastasis and poor outcome. Cancer J.
15:519–525. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakao A, Takeda S, Sakai M, Kaneko T,
Inoue S, Sugimoto H and Kanazumi N: Extended radical resection
versus standard resection for pancreatic cancer: the rationale for
extended radical resection. Pancreas. 28:289–292. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Büchler MW, Kleeff J and Friess H:
Surgical treatment of pancreatic cancer. J Am Coll Surg. 205(4
Suppl): S81–S86. 2007.
|
|
27
|
Koliopanos A, Avgerinos C, Farfaras A,
Manes C and Dervenis C: Radical resection of pancreatic cancer.
Hepatobiliary Pancreat Dis Int. 7:11–18. 2008.
|
|
28
|
Müller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL,
Mohar A, Verástegui E and Zlotnik A: Involvement of chemokine
receptors in breast cancer metastasis. Nature. 410:50–56.
2001.PubMed/NCBI
|
|
29
|
Nakata B, Fukunaga S, Noda E, Amano R,
Yamada N and Hirakawa K: Chemokine receptor CCR7 expression
correlates with lymph node metastasis in pancreatic cancer.
Oncology. 74:69–75. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang RF, Wang SX, Peng L, Wang SX, Zhang
M, Li ZF, Zhang ZM, Xiao Y and Zhang FR: Expression of vascular
endothelial growth factors A and C in human pancreatic cancer.
World J Gastroenterol. 12:280–286. 2006.PubMed/NCBI
|
|
31
|
Kurahara H, Takao S, Maemura K, Shinchi H,
Natsugoe S and Aikou T: Impact of vascular endothelial growth
factor-C and -D expression in human pancreatic cancer: its
relationship to lymph node metastasis. Clin Cancer Res.
10:8413–8420. 2004. View Article : Google Scholar
|
|
32
|
Wehler T, Wolfert F, Schimanski CC, Gockel
I, Herr W, Biesterfeld S, Seifert JK, Adwan H and Berger MR: Strong
expression of chemokine receptor CXCR4 by pancreatic cancer
correlates with advanced disease. Oncol Rep. 16:1159–1164.
2006.PubMed/NCBI
|
|
33
|
Niu ZX, Fei LM and Wang CL: Expression of
CXCL12-CXCR4 and its association with angiogenesis in pancreatic
cancer. Zhonghua Zhong Liu Za Zhi. 31:286–287. 2009.(In
Chinese).
|
|
34
|
Neel NF, Schutyser E, Sai J, Fan GH and
Richmond A: Chemokine receptor internalization and intracellular
trafficking. Cytokine Growth Factor Rev. 16:637–658. 2005.
View Article : Google Scholar : PubMed/NCBI
|
